Top

Published in:

01-06-2019 | Original Paper

Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers

Authors: M. Shayne Gallaway, Bin Huang, Quan Chen, Thomas C. Tucker, Jaclyn K. McDowell, Eric Durbin, Sherri L. Stewart, Eric Tai

Published in: Journal of Community Health | Issue 3/2019

Abstract

Purpose

To examine smoking and use of smoking cessation aids among tobacco-associated cancer (TAC) or non-tobacco-associated cancer (nTAC) survivors. Understanding when and if specific types of cessation resources are used can help with planning interventions to more effectively decrease smoking among all cancer survivors, but there is a lack of research on smoking cessation modalities used among cancer survivors.

Methods

Kentucky Cancer Registry data on incident lung, colorectal, pancreatic, breast, ovarian, and prostate cancer cases diagnosed 2007–2011, were linked with health administrative claims data (Medicaid, Medicare, private insurers) to examine the prevalence of smoking and use of smoking cessation aids 1 year prior and 1 year following the cancer diagnosis. TACs included colorectal, pancreatic, and lung cancers; nTAC included breast, ovarian, and prostate cancers.

Results

There were 10,033 TAC and 13,670 nTAC survivors. Smoking before diagnosis was significantly higher among TAC survivors (p < 0.0001). Among TAC survivors, smoking before diagnosis was significantly higher among persons who: were males (83%), aged 45–64 (83%), of unknown marital status (84%), had very low education (78%), had public insurance (89%), Medicaid (85%) or were uninsured (84%). Smoking cessation counseling and pharmacotherapy were more common among TAC than nTAC survivors (p < 0.01 and p = 0.05, respectively).

Discussion

While smoking cessation counseling and pharmacotherapy were higher among TAC survivors, reducing smoking among all cancer survivors remains a priority, given cancer survivors are at increased risk for subsequent chronic diseases, including cancer. Tobacco cessation among all cancer survivors (not just those with TAC) can help improve prognosis, quality of life and reduce the risk of further disease. Health care providers can recommend for individual, group and telephone counseling and/or pharmacotherapy recommendations. These could also be included in survivorship care plans.

Babb, S. (2017). Quitting smoking among adults—United States, 2000–2015. Morbidity and Mortality Weekly Report, 65(52), 1457–1464.CrossRefPubMed

Bellizzi, K., Rowland, J., Jeffery, D., & McNeel, T. (2005). Health behaviors of cancer survivors: examining opportunities for cancer control intervention. Journal of Clinical Oncology, 23(34), 8884–8893.CrossRefPubMed

Berg, C. J., Thomas, A., Mertens, A., Schauer, G., Pinsker, E., Ahluwalia, J., & Khuri, F. (2013). Correlates of continued smoking versus cessation among survivors of smoking-related cancers. Psycho-oncology, 22(4), 799–806.CrossRefPubMed

Berube, S., Lemieux, J., Moore, L., Maunsell, E., & Brisson, J. (2014). Smoking at time of diagnosis and breast cancer-specific survival: new findings and systematic review with meta-analysis. Breast Cancer Research, 16(2), R42. https://doi.org/10.1186/bcr3646.CrossRefPubMed

Brand, R. E., Greer, J. B., Zolotarevsky, E., Brand, R., Du, H., Simeone, D., et al. (2009). Pancreatic cancer patients who smoke and drink are diagnosed at younger ages. Clinical Gastroenterology and Hepatology, 7(9), 1007–1012. https://doi.org/10.1016/j.cgh.2009.06.008.CrossRefPubMedPubMedCentral

Browman, G., Browman, G. P., Wong, G., Hodson, I., Sathya, J., Russell, R., et al. (1993). Influence of cigarette smoking on the efficacy of radiation therapy in head and neck cancer. The New England Journal of Medicine, 328(3), 159–163.CrossRefPubMed

Cahill, K., Stead, L., & Lancaster, T. (1996). Nicotine receptor partial agonists for smoking cessation. Cochrane Database of Systematic Reviews, The Cochrane Library. https://doi.org/10.1002/14651858.CD006103.pub6.CrossRef

Caraballo, R. S., Shafer, P. R., Patel, D., Davis, K. C., & McAfee, T. A. (2017). Quit methods used by US adult cigarette smokers, 2014–2016. Preventing Chronic Disease, 14(E32), 1–5.

Carter, B. D., Abnet, C. C., Feskanich, D., Freedman, N. D., Hartge, P., Lewis, C. E., et al. (2015). Smoking and mortality–beyond established causes. N Engl J Med, 372(7), 631–640. https://doi.org/10.1056/NEJMsa1407211.CrossRefPubMed

10.

Centers for Disease Control and Prevention, & Office of Smoking and Health. (2018). National Tobacco Control Program. Retrieved from https://www.cdc.gov/tobacco/stateandcommunity/tobacco_control_programs/ntcp/index.htm.

11.

Comprehensive Cancer Control National Partnership. (2016). Increase availability of tobacco cessation services for cancer survivors. Retrieved from http://www.cccnationalpartners.org/increase-availability-tobacco-cessation-services-cancer-survivors.

12.

Cox, L., Africano, N., Tercyak, K., & Taylor, K. (2003). Nicotine dependence treatment for patients with cancer. Cancer, 98(3), 632–644.CrossRefPubMed

13.

Crystal, S., Akincigil, A., Bilder, S., & Walkup, J. T. (2007). Studying prescription drug use and outcomes with medicaid claims data: strengths, limitations, and strategies. Medical Care, 45(10 Supl 2), S58–S65. https://doi.org/10.1097/MLR.0b013e31805371bf.CrossRefPubMedPubMedCentral

14.

Department of Health and Human Services, & Centers for Disease Control and Prevention. (2015). Increasing the implementation of evidence-based cancer survivorship interventions to increase quality and duration of life among cancer patients. Retrieved from https://www.grants.gov/view-opportunity.html?oppId=274757.

15.

Des Rochers, C., Dische, S., & Saunders, M. I. (1992). The problem of cigarette smoking in radiotherapy for cancer in the head and neck. Clinical Oncology, 4(4), 214–216.CrossRefPubMed

16.

Division of Cancer Prevention and Control Centers for Disease Control and Prevention. (2017, March 7th, 2017). National comprehensive cancer control program (NCCCP). Retrieved from https://www.cdc.gov/cancer/ncccp/.

17.

Earle, C. C., & Neville, B. (2004). Under use of necessary care among cancer survivors. Cancer, 101(8), 1712–1719.CrossRefPubMed

18.

Edwards, S. A., Bondy, S., Callaghan, R., & Mann, R. (2014). Prevalence of unassisted quit attempts in population-based studies: A systematic review of the literature. Addictive Behaviors, 39(3), 512–519.CrossRefPubMed

19.

Emmons, K., Li, F., Whitton, J., Mertens, A., Hutchinson, R., Diller, L., & Robison, L. (2002). Predictors of smoking initiation and cessation among childhood cancer survivors: a report from the childhood cancer survivor study. Journal of Clinical Oncology, 20(6), 1608–1616.CrossRefPubMed

20.

Fairley, T. (2009). Health behaviors and quality of life of cancer survivors in Massachusetts, 2006: Data use for comprehensive cancer control. Preventing chronic disease. 7(1), A09.PubMedPubMedCentral

21.

Fiore, M. C., Jaen, C. R., Baker, T. B., Bailey, W. C., Benowitz, N. L., Curry, S. J., et al. (2008). Treating tobacco use and dependence: 2008 Update. Clinical Practice Guideline. Rockville: U.S. Department of Health and Human Services, Public Health Service.

22.

Gallaway, M. S., Glover-Kudon, R., Momin, B., Puckett, M., Lunsford, N. B., Ragan, K. R., et al. (2018). Smoking cessation attitudes and practices among Cancer Survivors–United States, 2015. J Cancer Surviv. https://doi.org/10.1007/s11764-018-0728-2 CrossRef

23.

Goldstein, A. O., Ripley-Moffitt, C. E., Pathman, D. E., & Patsakham, K. M. (2013). Tobacco use treatment at the U.S. National Cancer Institute’s designated cancer centers. Nicotine & Tobacco Research, 15(1), 52–58.CrossRef

24.

Gritz, E. (2005). Smoking, the missing drug interaction in clinical trials: ignoring the obvious. Cancer Epidemiology, Biomarkers & Prevention, 14(10), 2287–2293.CrossRef

25.

Gritz, E. R., Fingeret, M., Vidrine, D., Lazev, A., Mehta, N., & Reece, G. (2006). Successes and failures of the teachable moment. Cancer, 106(1), 17–27.CrossRefPubMed

26.

Henley, S. J., Thomas, C., Sharapova, S., Momin, B., Massetti, G., Winn, D., et al. (2016). Vital Signs: disparities in tobacco-related cancer incidence and mortality—United States, 2004–2013. MMWR. Morbidity and Mortality Weekly Report, 65(44), 1212–1218.CrossRefPubMed

27.

Hughes, J. R., & Callas, P. W. (2010). Definition of a quit attempt: a replication test. Nicotine & Tobacco Research, 12(11), 1176–1179.CrossRef

28.

Jamal, A., Homa, D., Oconnor, E., Babb, S., Caraballo, R., Singh, T., et al. (2015). Current cigarette smoking among adults—United States, 2005–2014. MMWR. Morbidity and Mortality Weekly Report, 64(44), 1233–1240.CrossRefPubMed

29.

Kawahara, M., Ushijima, S., Kamimori, T., Kodama, N., Ogawara, M., Matsui, K., et al. (1998). Second primary tumours in more than 2-year disease-free survivors of small-cell lung cancer in Japan: the role of smoking cessation. British Journal of Cancer, 78(3), 409–412.CrossRefPubMedPubMedCentral

30.

Klosky, J. L., Tyc, V., Garces Webb, D., Buscemi, J., Klesges, R., & Hudson, M. (2007). Emerging issues in smoking among adolescent and adult cancer survivors. Cancer, 110(11), 2408–2419.CrossRefPubMed

31.

Lancaster, T., & Stead, L. (1996). Individual behavioural counselling for smoking cessation. Cochrane Database of Systematic Reviews, The Cochrane Library. https://doi.org/10.1002/14651858.CD001292.pub2.CrossRef

32.

Lortet-Tieulent, J., Goding Sauer, A., Siegel, R. L., Miller, K. D., Islami, F., Fedewa, S. A., et al. (2016). State-level cancer mortality attributable to cigarette smoking in the United States. JAMA Internal Medicine, 176(12), 1792–1798. https://doi.org/10.1001/jamainternmed.2016.6530.CrossRefPubMed

33.

Mackenbach, J. P. (2001). Determinants of levels and changes of physical functioning in chronically ill persons: Results from the GLOBE Study. Journal of Epidemiology and Community Health, 55(9), 631–638.CrossRefPubMedPubMedCentral

34.

Mariotto, A. (2007). Multiple cancer prevalence: a growing challenge in long-term survivorship. Cancer Epidemiology, Biomarkers & Prevention, 16(3), 566–571.CrossRef

35.

Mason, D. P., Subramanian, S., Nowicki, E., Grab, J., Murthy, S., Rice, T., & Blackstone, E. (2009). Impact of smoking cessation before resection of lung cancer: a society of thoracic surgeons general thoracic surgery database study. The Annals of Thoracic Surgery, 88(2), 362–371.CrossRefPubMed

36.

National Cancer Institute, National Institute of Health, & Department of Health and Human Services. (January 2017). Cancer Trends Progress Report. Retrieved from https://progressreport.cancer.gov.

37.

Passarelli, M. N., Newcomb, P. A., Hampton, J. M., Trentham-Dietz, A., Titus, L. J., Egan, K. M., et al. (2016). Cigarette smoking before and after breast cancer diagnosis: mortality from breast cancer and smoking-related diseases. Journal of Clinical Oncology, 34(12), 1315–1322. https://doi.org/10.1200/JCO.2015.63.9328.CrossRefPubMedPubMedCentral

38.

Polednak, A. P. (2006). Obtaining smoking histories for population-based studies on multiple primary cancers: Connecticut, 2002. International Journal of Cancer, 119(1), 233–235. https://doi.org/10.1002/ijc.21786.CrossRefPubMed

39.

Richardson, G. E. (1993). Smoking cessation after successful treatment of small-cell lung cancer is associated with fewer smoking-related second primary cancers. Annals of Internal Medicine, 119(5), 383–390.CrossRefPubMed

40.

Sabatino, S. (2007). Provider counseling about health behaviors among cancer survivors in the United States. Journal of Clinical Oncology, 25(15), 2100–2106.CrossRefPubMed

41.

Sharp, L., McDevitt, J., Brown, C., & Comber, H. (2017). Smoking at diagnosis significantly decreases 5-year cancer-specific survival in a population-based cohort of 18,166 colon cancer patients. Alimentary Pharmacology and Therapeutics, 45(6), 788–800. https://doi.org/10.1111/apt.13944.CrossRefPubMed

42.

Shiels, M. S., Gibson, T., Sampson, J., Albanes, D., Andreotti, G., Freeman, L. B., et al (2014). Cigarette smoking prior to first cancer and risk of second smoking-associated cancers among survivors of bladder, kidney, head and neck, and stage I lung cancers. Journal of Clinical Oncology, 32(35), 3989–3995. https://doi.org/10.1200/JCO.2014.56.8220.CrossRefPubMedPubMedCentral

43.

Silagy, C. (1994). Nicotine replacement therapies in smoking cessation. Biomedicine & Pharmacotherapy, 48(8–9), 407–408.CrossRef

44.

Siu, A. L. (2015). Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: U.S. Preventive Services Task Force recommendation statement. Annals of Internal Medicine, 163(8), 622–634.CrossRefPubMed

45.

Stead, L. (2010). Group behaviour therapy programmes for smoking cessation. Canadian Journal of Dental Hygiene, 44(2), 84.

46.

Stead, L., & Young, T. (2005). Cochrane Column. International Journal of Epidemiology, 34(5), 1001–1003.CrossRef

47.

Stewart, S. L., Cardinez, C. J., Richardson, L. C., Norman, L., Kaufmann, R., Pechacek, T. F., et al. (2008). Surveillance for cancers associated with tobacco use—United States, 1999–2004. MMWR Surveill Summ, 57(8), 1–33.PubMed

48.

Tucker, M. A. (1997). Second primary cancers related to smoking and treatment of small-cell lung cancer. Lung Cancer Working Cadre. Journal of the National Cancer Institute, 89(23), 1782–1788.CrossRefPubMed

49.

Tyc, V. L. (2005). A comparison of tobacco-related risk factors between adolescents with and without cancer. Journal of Pediatric Psychology, 30(4), 359–370.CrossRefPubMed

50.

U.S. Cancer Statistics Working Group. (2017). U.S. Cancer Statistics Publication Criteria. Retrieved from https://www.cdc.gov/cancer/npcr/uscs/technical_notes/criteria.htm.

51.

U.S. Department of Health and Human Services. (2014). The health consequences of smoking: 50 years of progress: A report of the surgeon general. Retrieved from Atlanta, Georgia. https://www.surgeongeneral.gov/library/reports/50-years-of-progress/index.html.

52.

Underwood, J. M., Townsend, J., Stewart, S. L., Buchannan, N., Ekwueme, D. U., Hawkins, N. A., et al. (2012). Surveillance of demographic characteristics and health behaviors among adult cancer survivors—behavioral risk factor surveillance system, United States, 2009. Morbidity and Mortality Weekly Report, 61(1), 1–23.

53.

Underwood, J. M., Townsend, J., Tai, E., White, A., Davis, S., & Fairley, T. (2012). Persistent cigarette smoking and other tobacco use after a tobacco-related cancer diagnosis. Journal of Cancer Survivorship, 6(3), 333–344.CrossRefPubMedPubMedCentral

54.

Warren, G. W., Kasza, K. A., Reid, M. E., Cummings, K. M., & Marshall, J. R. (2013). Smoking at diagnosis and survival in cancer patients. International Journal of Cancer, 132(2), 401–410. https://doi.org/10.1002/ijc.27617.CrossRefPubMed

55.

Weaver, K. E., Danhauer, S. C., Tooze, J. A., Blackstock, A. W., Spangler, J., Thomas, L., & Sutfin, E. L. (2012). Smoking cessation counseling beliefs and behaviors of outpatient oncology providers. The Oncologist, 17(3), 455–462.CrossRefPubMedPubMedCentral

56.

Westmaas, J. L., Newton, C. C., Stevens, V. L., Flanders, W. D., Gapstur, S. M., & Jacobs, E. J. (2015). Does a recent cancer diagnosis predict smoking cessation? An analysis from a large prospective US cohort. Journal of Clinical Oncology, 33(15), 1647–1652. https://doi.org/10.1200/JCO.2014.58.3088.CrossRefPubMed

57.

Wiley, L. K., Shah, A., Xu, H., & Bush, W. S. (2013). ICD-9 tobacco use codes are effective identifiers of smoking status. Journal of the American Medical Informatics Association, 20(4), 652–658. https://doi.org/10.1136/amiajnl-2012-001557.CrossRefPubMedPubMedCentral

Title: Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers
Authors: M. Shayne Gallaway
Bin Huang
Quan Chen
Thomas C. Tucker
Jaclyn K. McDowell
Eric Durbin
Sherri L. Stewart
Eric Tai
Publication date: 01-06-2019
Publisher: Springer US
Published in: Journal of Community Health / Issue 3/2019
Print ISSN: 0094-5145
Electronic ISSN: 1573-3610
DOI: https://doi.org/10.1007/s10900-019-00622-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Smoking and Smoking Cessation Among Persons with Tobacco- and Non-tobacco-Associated Cancers

Abstract

Purpose

Methods

Results

Discussion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Purpose

Methods

Results

Discussion

Please log in to get access to this content

Other articles of this Issue 3/2019

The Association Between Perceived Stress and Hypertension Among Asian Americans: Does Social Support and Social Network Make a Difference?

The Impact of the Affordable Care Act Medicaid Expansion on Type 2 Diabetes Diagnosis and Treatment: A National Survey of Physicians

Ancillary Benefit of Increased HPV Immunization Rates Following a CBPR Approach to Address Immunization Disparities in Younger Siblings

Barriers to Disease Monitoring and Liver Cancer Surveillance Among Patients with Chronic Hepatitis B in the United States

College Students’ Perception of Current and Projected 30-Year Cardiovascular Disease Risk Using Cluster Analysis with Internal Validation

Free-Floating Bikeshare and Helmet Use in Seattle, WA